26 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or intellectual property experts (it being agreed that such consultant or expert fees, expenses and disbursements shall be limited to one such consultant … and one such expert for the Collateral Agent, Lenders and such Related Parties, taken as a whole) therefor, (i) incurred in connection with developing
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
and withdraw the dispute from arbitration. The Independent Accounting Firm shall (i) act as an independent accounting firm and not as an expert, (ii) address
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
under the circumstances. However, costs do not include attorneys and expert witness fees. Each stockholder is responsible for its own attorneys and expert
S-4/A
CHRS
Coherus Biosciences Inc
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
as the Delaware Court of Chancery deems to be equitable under the circumstances. However, costs do not include attorneys and expert witness fees. Each … stockholder is responsible for its own attorneys and expert witnesses expenses, although, upon application of a stockholder, the Delaware Court of Chancery
S-4
mbzj2od2n1k1ifjjxlg
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
S-4
EX-99.1
2ugexb272dv 0yc
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
8-K
EX-99.1
q4vu03y60euag7w3c2f2
14 May 18
Departure of Directors or Certain Officers
5:22pm
8-K
EX-99.1
7tb47802d0bz8 8qenps
10 Apr 17
Departure of Directors or Certain Officers
12:00am
10-K
nlt5t3t
23 Mar 15
Annual report
12:00am
424B4
gonr2btufl6v r1a
6 Nov 14
Prospectus supplement with pricing info
12:00am